Insiders AstraZeneca Pharma India Limited

Equities

ASTRAZEN

INE203A01020

Delayed Bombay S.E. Other stock markets 12:44:06 2024-05-21 am EDT			5-day change	1st Jan Change
5,797 ^INR	+0.69%		+6.48%	+5.03%

Apr. 08	AstraZeneca Pharma India Limited Approves Appointment of Bhavana Agrawal as Director and Whole Time Director	CI
Mar. 25	AstraZeneca Pharma India Limited Appoints Vinay Sharma as Business Unit Head - Rare Disease, Effective July 1, 2024	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

AstraZeneca Pharma India Limited Approves Appointment of Bhavana Agrawal as Director and Whole Time Director	Apr. 08	CI
AstraZeneca Pharma India Limited Appoints Vinay Sharma as Business Unit Head - Rare Disease, Effective July 1, 2024	Mar. 25	CI
Astrazeneca Pharma India Limited Announces Board Changes	Feb. 19	CI
AstraZeneca Pharma India Limited Announces Board Changes	Feb. 08	CI
AstraZeneca Pharma India Limited Announces Directorate Appointments	Feb. 07	CI
Astrazeneca Pharma India Limited Appoints Hooi-Bien Chuah as Additional Director (Non-Executive)	Nov. 09	CI
Astrazeneca Pharma India Limited Announces Retirement of Rajesh Marwaha as Whole-Time Director	23-09-29	CI
AstraZeneca Pharma India Limited Appoints Praveen Akkinepally as the Business Unit Head Oncology with Effect from November 1, 2023	23-09-15	CI
AstraZeneca Pharma India Limited Announces Executive Changes	23-07-31	CI
Astrazeneca Pharma India Names CFO	23-05-30	MT
AstraZeneca Pharma India Limited Announces Retirement of Mr. Rajesh Marwaha from the Office of Whole-Time Director, Effective September 30, 2023	23-05-30	CI
Astrazeneca Pharma India Appoints Managing Director	22-12-14	MT
Astrazeneca Pharma India Limited Announces Resignation of Gagandeep Singh Bedi as Director, Effective December 31, 2022	22-12-14	CI
AstraZeneca Pharma India Limited Announces Resignation of Gagandeep Singh Bedi as Managing Director, Effective December 31, 2022	22-12-14	CI
AstraZeneca Pharma India Limited Appoints Sanjeev Panchal as Country President	22-12-13	CI
Astrazeneca Pharma India Limited Appoints Sanjeev Panchal as Managing Director	22-12-13	CI
Astrazeneca Pharma India Limited Appoints Shilpa Shridhar Divekar, as an Independent Director	22-08-10	CI
AstraZeneca Pharma India Limited Announces Executive Changes	22-08-08	CI
Astrazeneca Pharma India Limited Announces Resignation of Kimsuka Narsimhan as Independent Director, At the Close of Business Hours on February 1, 2022	22-02-02	CI
AstraZeneca Pharma India Limited Appoints Shilpa Shridhar Divekar as Additional Director (Non-Executive & Independent) of the Company	21-12-30	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders AstraZeneca Pharma India Limited

Equities

ASTRAZEN

INE203A01020

Insiders

Filters